Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial-Reference-Cited by-同舟云学术

Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

Published:2021-01 Issue:1 Volume:32 Page:120-121
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Hiltbrunner S.,Britschgi C.,Schuberth P.,Bankel L.,Nguyen-Kim T.D.L.,Gulati P.,Weder W.,Opitz I.,Lauk O.,Caviezel C.,Bachmann H.,Tabor A.,Schröder P.,Knuth A.,Münz C.,Stahel R.,Boyman O.,Renner C.,Petrausch U.,Curioni-Fontecedro A.

Funder

Swiss Cancer Research Foundation

Universität Zürich

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference5 articles.

1. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial;Stahel;Lancet Oncol,2015

2. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

3. Aberrant Lck signal via CD28 costimulation augments antigen-specific functionality and tumor control by redirected T cells with PD-1 blockade in humanized mice;Gulati;Clin Cancer Res,2018

4. Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1);Petrausch;BMC Cancer,2012

5. Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010;Ertl;Cancer Res,2011

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights;Frontiers in Immunology;2024-09-05

2. Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors;Cancer Science;2024-08-21

3. CAFs and T cells interplay: The emergence of a new arena in cancer combat;Biomedicine & Pharmacotherapy;2024-08

4. TALEN-edited allogeneic inducible dual CAR T cells enable effective targeting of solid tumors while mitigating off-tumor toxicity;Molecular Therapy;2024-08

5. Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors;BioDrugs;2024-07-30